Black Rock Inc. I Teos Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ITOS
# of Institutions
142Shares Held
30.2MCall Options Held
84.6KPut Options Held
32.2K-
Mpm Asset Management LLC Cambridge, MA2.74MShares$40.5 Million15.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2MShares$29.5 Million0.78% of portfolio
-
Boxer Capital, LLC San Diego, CA1.8MShares$26.7 Million1.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$25.8 Million3.9% of portfolio
-
Morgan Stanley New York, NY1.63MShares$24.1 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $526M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...